BTMD Financials

Income Statement
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Revenue
44.2M
-1.6%
44.9M
-3.2%
46.4M
-3.2%
48.0M
-1.9%
48.9M
Cost of Revenue
15.3M
+9.5%
14.0M
-5.7%
14.8M
+9.6%
13.5M
-2.4%
13.9M
Gross Profit
28.9M
-6.6%
31.0M
-2.0%
31.6M
-8.3%
34.4M
-1.6%
35.0M
Operating Expenses
33.1M
+19.0%
27.8M
+12.3%
24.7M
-5.4%
26.2M
+8.0%
24.2M
R&D
SG&A
32.4M
+16.7%
27.8M
+12.3%
24.7M
-5.4%
26.2M
+8.0%
24.2M
Operating Income
-4156000
-231.3%
3.2M
-53.6%
6.8M
-17.4%
8.3M
-23.2%
10.8M
EBITDA
-2545000
-161.4%
4.1M
-46.7%
7.8M
-15.6%
9.2M
-21.0%
11.7M
Net Income
-7428000
-377.6%
2.7M
+2.3%
2.6M
-71.6%
9.2M
+134.8%
3.9M
EPS (Basic)
$-0.23
-428.6%
$0.07
+16.7%
$0.06
-76.9%
$0.26
+160.0%
$0.10
EPS (Diluted)
$-0.23
-483.3%
$0.06
+20.0%
$0.05
-77.3%
$0.22
+120.0%
$0.10
Shares (Diluted)
28.6M
-20.5%
36.0M
-12.8%
41.3M
+12.4%
36.7M
+15.6%
31.7M
Biote (BTMD) — Financials